UNAUDITED CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Jan. 31, 2020	Jan. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES
Net (Loss) Income	$ (16,592,577)	$ 5,397,996
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization	407,141	378,200
Amortization of operating lease right-of-use assets	45,128	0
Shares issued for services	1,236,697	924,845
Stock compensation expense	243,600	0
Changes in fair value of contingent purchase consideration	0	(15,147,591)
Amortization of debt discount	2,955,576	0
Change in fair value of derivative liabilities - convertible notes	(1,406,799)	(177,844)
Change in fair value of derivative liabilities - convertible warrants	51,823	35,119
Change in fair value of derivative liabilities - downside protection	5,000,966	0
Change in fair value of common stock payable	(115,054)	0
Impairment of long-lived assets	0	99,519
Bad debt expense	10,981	0
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable	(81,320)	686,889
Inventory	(232,015)	385,987
Accounts payable and accrued expenses	4,136,266	3,296,630
Accrued interest on notes receivable	0	(18,288)
Operating lease liabilities	(44,338)	0
Other current assets	(216,352)	2,936
Other assets	2,183	(10,997)
Other current liabilities	0	4,620
Other liabilities	0	171,562
Net cash used in operating activities	(4,598,094)	(3,970,417)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment	(4,616)	(26,671)
Purchase of intangible assets	0	(26,488)
Cash received in acquisition of a business, net of cash paid	49,305	1,722,814
Net cash provided by investing activities	44,689	1,669,655
CASH FLOWS FROM FINANCING ACTIVITIES
Loan proceeds from (repayments to) related party	10,000	(3,305)
Payment of notes payable	(935,731)	(28,640)
Proceeds from note payable	5,361,975	3,524,460
Proceeds from issuance of common stock	109,770	0
Investment in subsidiary by noncontrolling interest	0	133,679
Net cash provided by financing activities	4,546,014	3,626,194
Effects of currency rate exchange on cash	(22,025)	2,024
Net (decrease) increase in cash and cash equivalents	(29,416)	1,327,456
Cash and cash equivalents, beginning of period	298,485	1,046,365
Cash and cash equivalents, end of period	269,069	2,373,821
Supplemental Disclosure of Cash Flow Information
Cash paid for interest	25,000	0
Cash paid for taxes	0	0
Supplemental Disclosure of Non-Cash Investing and Financing Activities
Reduction of derivative liabilities	2,276,078	0
Discount on derivative liability upon issuance of debt	1,574,685	165,833
Issuance of common stock for conversion of debt	2,904,695	0
Set up of ROU	210,698	0
Issuance of shares-common stock payable	921,895	0
Subscription receivable	765,970	0
Shares issued as debt issuance cost	141,990	0
Conversion of series H 9% convertible preferred stock to common stock	0	25,200
Conversion of series I 9% convertible preferred stock to common stock	0	6,631
Note payable issued for acquisition of a business	0	35,000,000
Acquisition of Veneto assets & liabilities - First Closing	0	(13,947,462)
Acquisition of Veneto assets & liabilities - Second Closing	0	(19,948,909)
Acquisition of Regentys assets & liabilities	0	(337,538)
Acquisition of Olaregen assets & liabilities	0	212,355
Extinguishment of HDS debt	0	(14,056,109)
Note payable issued for acquisition of a business	0	35,000,000
Market value of convertible notes	0	2,110,000
Derivative liability - convertible notes	0	2,530,983
Derivative liability - convertible warrants	$ 0	$ 157,552